{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T01:02:08Z","timestamp":1784682128815,"version":"3.55.0"},"reference-count":73,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T00:00:00Z","timestamp":1779148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T00:00:00Z","timestamp":1784678400000},"content-version":"vor","delay-in-days":64,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Ductal carcinoma in situ is a non-obligate precursor lesion of breast cancer. Often detected by mammography, most cases are managed through surgical and\/or radiotherapy approaches. Today, it is not possible to predict which patients will progress to invasive disease. Here, we evaluate high-depth whole-genome sequenced ductal carcinoma in situ, enriched for high-grade clinical lesions, to understand whether deep WGS could reveal biological insights and\/or personalized therapeutic vulnerabilities that may be targetable. We find genomic locations that are likely susceptible to producing the initiating lesion for structural variations prone to subsequent evolution, termed SHOREs. We additionally highlight individualized therapeutic potential that would otherwise not be appreciable without whole genome sequencing. We posit that holistic whole genome sequencing profiling could offer a more precise stratification approach, discerning higher-risk cases for prospective clinical studies on personalized therapies, from truly low-risk cases suitable for active monitoring.<\/jats:p>","DOI":"10.1038\/s41467-026-72952-1","type":"journal-article","created":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T17:04:07Z","timestamp":1779210247000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["High-depth whole genome sequencing of premalignant breast lesions reveals rearrangement hotspots and personalized management opportunities"],"prefix":"10.1038","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9905-0785","authenticated-orcid":false,"given":"Lucia","family":"Chmelova","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6381-3664","authenticated-orcid":false,"given":"Helen R.","family":"Davies","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6879-0596","authenticated-orcid":false,"given":"Andrea","family":"Degasperi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5650-6049","authenticated-orcid":false,"given":"Giuseppe","family":"Rinaldi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leon","family":"Wils","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniella","family":"Black","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasin","family":"Memari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3840-4954","authenticated-orcid":false,"given":"Gene C. C.","family":"Koh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott","family":"Shooter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lennart","family":"Mulder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petra","family":"Kristel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1228-4245","authenticated-orcid":false,"given":"Karoly","family":"Szuhai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4590-1278","authenticated-orcid":false,"given":"Gino","family":"Prasad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9761-3422","authenticated-orcid":false,"given":"Ivy Tsz-Lo","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4391-979X","authenticated-orcid":false,"given":"Jens","family":"Luebeck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yogesh","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Czarnecki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shadi","family":"Basyuni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zoya","family":"Kingsbury","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark T.","family":"Ross","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00d8ystein","family":"Garred","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margit","family":"Riis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karin T.","family":"Lande","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2195-0385","authenticated-orcid":false,"given":"Johan","family":"Vallon-Christersson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9225-7396","authenticated-orcid":false,"given":"Anna","family":"Ehinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3144-0493","authenticated-orcid":false,"given":"Amit","family":"Agrawal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4123-9611","authenticated-orcid":false,"given":"Stuart A.","family":"McIntosh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5810-6241","authenticated-orcid":false,"given":"Vineet","family":"Bafna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4560-2211","authenticated-orcid":false,"given":"Paul S.","family":"Mischel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"Grand Challenges PRECISION Consortium","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fariba","family":"Behbod","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Proteeti","family":"Bhattacharjee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deborah","family":"Collyar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen","family":"Davies","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Futreal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E. Shelley","family":"Hwang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos","family":"Jonkers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esther H.","family":"Lips","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas","family":"Navin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serena","family":"Nik-Zainal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donna","family":"Pinto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Rea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elinor J.","family":"Sawyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marjanka","family":"Schmidt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hilary","family":"Stobart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alastair","family":"Thompson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marja","family":"van Oirsouw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacco","family":"van Rheenen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ellen","family":"Verschuur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jelle","family":"Wesseling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lodewyk F. A.","family":"Wessels","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8940-2676","authenticated-orcid":false,"given":"Jelle","family":"Wesseling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5254-5115","authenticated-orcid":false,"given":"Johan","family":"Staaf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Therese","family":"S\u00f8rlie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3488-4935","authenticated-orcid":false,"given":"Esther H.","family":"Lips","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5054-1727","authenticated-orcid":false,"given":"Serena","family":"Nik-Zainal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,19]]},"reference":[{"key":"72952_CR1","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1093\/jncimonographs\/lgq027","volume":"2010","author":"K Kerlikowske","year":"2010","unstructured":"Kerlikowske, K. Epidemiology of ductal carcinoma in situ. JNCI Monogr. 2010, 139\u2013141 (2010).","journal-title":"JNCI Monogr."},{"key":"72952_CR2","doi-asserted-by":"publisher","first-page":"1438","DOI":"10.1056\/NEJMoa1600249","volume":"375","author":"HG Welch","year":"2016","unstructured":"Welch, H. G., Prorok, P. C., O\u2019Malley, A. J. & Kramer, B. S. Breast-cancer tumor size, overdiagnosis, and mammography screening effectiveness. N. Engl. J. Med. 375, 1438\u20131447 (2016).","journal-title":"N. Engl. J. Med."},{"key":"72952_CR3","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1007\/s10549-016-3973-y","volume":"159","author":"LE Elshof","year":"2016","unstructured":"Elshof, L. E., Schaapveld, M., Schmidt, M. K., Rutgers, E. J., van Leeuwen, F. E. & Wesseling, J. Subsequent risk of ipsilateral and contralateral invasive breast cancer after treatment for ductal carcinoma in situ: incidence and the effect of radiotherapy in a population-based cohort of 10,090 women. Breast Cancer Res. Treat. 159, 553\u2013563 (2016).","journal-title":"Breast Cancer Res. Treat."},{"key":"72952_CR4","first-page":"145","volume":"61","author":"AJ Maxwell","year":"2022","unstructured":"Maxwell, A. J., Hilton, B., Clements, K., Dodwell, D., Dulson-Cox, J., Kearins, O. et al. Unresected screen-detected ductal carcinoma in situ: Outcomes of 311 women in the Forget-Me-Not 2 study. Breast J. Eur. Soc. Mastol. 61, 145\u2013155 (2022).","journal-title":"Breast J. Eur. Soc. Mastol."},{"key":"72952_CR5","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1093\/jnci\/djy220","volume":"111","author":"MD Ryser","year":"2019","unstructured":"Ryser, M. D., Weaver, D. L., Zhao, F., Worni, M., Grimm, L. J., Gulati, R. et al. Cancer outcomes in DCIS patients without locoregional treatment. JNCI J. Natl. Cancer Inst. 111, 952\u2013960 (2019).","journal-title":"JNCI J. Natl. Cancer Inst."},{"key":"72952_CR6","doi-asserted-by":"crossref","unstructured":"Schmitz RSJM, Engelhardt E. G., Gerritsma M. A., Sondermeijer C. M. T., Verschuur E., Houtzager J. et al. Active surveillance versus treatment in low-risk DCIS: women\u2019s preferences in the LORD-trial. Eur. J. Cancer 192, 113276 (2023).","DOI":"10.1016\/j.ejca.2023.113276"},{"key":"72952_CR7","doi-asserted-by":"publisher","first-page":"2296","DOI":"10.1016\/j.ejca.2015.07.017","volume":"51","author":"A Francis","year":"2015","unstructured":"Francis, A., Thomas, J., Fallowfield, L., Wallis, M., Bartlett, J. M. S., Brookes, C. et al. Addressing overtreatment of screen detected DCIS; the LORIS trial. Eur. J. Cancer 51, 2296\u20132303 (2015).","journal-title":"Eur. J. Cancer"},{"key":"72952_CR8","doi-asserted-by":"publisher","first-page":"972","DOI":"10.1001\/jama.2024.26698","volume":"333","author":"ES Hwang","year":"2025","unstructured":"Hwang, E. S., Hyslop, T., Lynch, T., Ryser, M. D., Weiss, A., Wolf, A. et al. Active monitoring with or without endocrine therapy for low-risk ductal carcinoma in situ: the COMET randomized clinical trial. JAMA 333, 972\u2013980 (2025).","journal-title":"JAMA"},{"key":"72952_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.breast.2024.103764","volume":"77","author":"EG Engelhardt","year":"2024","unstructured":"Engelhardt, E. G., Schmitz, R. S. J. M., Gerritsma, M. A., Sondermeijer, C. M. T., Verschuur, E., Houtzager, J. H. E. et al. DCIS knowledge of women choosing between active surveillance and surgery for low-risk DCIS. Breast 77, 103764 (2024).","journal-title":"Breast"},{"key":"72952_CR10","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1038\/nature17676","volume":"534","author":"S Nik-Zainal","year":"2016","unstructured":"Nik-Zainal, S., Davies, H., Staaf, J., Ramakrishna, M., Glodzik, D., Zou, X. et al. Landscape of somatic mutations in 560 breast cancer whole-genome sequences. Nature 534, 47\u201354 (2016).","journal-title":"Nature"},{"key":"72952_CR11","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1016\/S1470-2045(25)00400-0","volume":"26","author":"D Black","year":"2025","unstructured":"Black, D., Davies, H. R., Koh, G. C. C., Chmelova, L., Cubric, M., Chan, G. C. et al. Clinical potential of whole-genome data linked to mortality statistics in patients with breast cancer in the UK: a retrospective analysis. Lancet Oncol. 26, 1417\u20131431 (2025).","journal-title":"Lancet Oncol."},{"key":"72952_CR12","doi-asserted-by":"publisher","first-page":"2690","DOI":"10.1016\/j.celrep.2019.04.098","volume":"27","author":"LD Mattos-Arruda","year":"2019","unstructured":"Mattos-Arruda, L. D., Sammut, S. J., Ross, E. M., Bashford-Rogers, R., Greenstein, E., Markus, H. et al. The genomic and immune landscapes of lethal metastatic breast cancer. Cell Rep. 27, 2690\u20132708.e10 (2019).","journal-title":"Cell Rep."},{"key":"72952_CR13","doi-asserted-by":"publisher","first-page":"1450","DOI":"10.1038\/s41588-019-0507-7","volume":"51","author":"L Angus","year":"2019","unstructured":"Angus, L., Smid, M., Wilting, S. M., van Riet, J., Van Hoeck, A., Nguyen, L. et al. The genomic landscape of metastatic breast cancer highlights changes in mutation and signature frequencies. Nat. Genet. 51, 1450\u20131458 (2019).","journal-title":"Nat. Genet."},{"key":"72952_CR14","doi-asserted-by":"publisher","first-page":"5317","DOI":"10.1158\/1078-0432.CCR-21-1239","volume":"27","author":"MA Thorat","year":"2021","unstructured":"Thorat, M. A., Levey, P. M., Jones, J. L., Pinder, S. E., Bundred, N. J., Fentiman, I. S. et al. Prognostic and predictive value of HER2 expression in ductal carcinoma in situ: results from the UK\/ANZ DCIS randomized trial. Clin. Cancer Res. 27, 5317\u20135324 (2021).","journal-title":"Clin. Cancer Res."},{"key":"72952_CR15","doi-asserted-by":"publisher","first-page":"m1570","DOI":"10.1136\/bmj.m1570","volume":"369","author":"GS Mannu","year":"2020","unstructured":"Mannu, G. S., Wang, Z., Broggio, J., Charman, J., Cheung, S., Kearins, O. et al. Invasive breast cancer and breast cancer mortality after ductal carcinoma in situ in women attending for breast screening in England, 1988-2014: population based observational cohort study. BMJ 369, m1570 (2020).","journal-title":"BMJ"},{"key":"72952_CR16","doi-asserted-by":"publisher","first-page":"e076022","DOI":"10.1136\/bmj-2023-076022","volume":"383","author":"RSJM Schmitz","year":"2023","unstructured":"Schmitz, R. S. J. M., van den Belt-Dusebout, A. W., Clements, K., Ren, Y., Cresta, C., Timbres, J. et al. Association of DCIS size and margin status with risk of developing breast cancer post-treatment: multinational, pooled cohort study. BMJ 383, e076022 (2023).","journal-title":"BMJ"},{"key":"72952_CR17","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1038\/s41588-022-01082-3","volume":"54","author":"EH Lips","year":"2022","unstructured":"Lips, E. H., Kumar, T., Megalios, A., Visser, L. L., Sheinman, M., Fortunato, A. et al. Genomic analysis defines clonal relationships of ductal carcinoma in situ and recurrent invasive breast cancer. Nat. Genet. 54, 850\u2013860 (2022).","journal-title":"Nat. Genet."},{"key":"72952_CR18","doi-asserted-by":"publisher","DOI":"10.1126\/science.abl9283","volume":"376","author":"A Degasperi","year":"2022","unstructured":"Degasperi, A., Zou, X., Dias Amarante, T., Martinez-Martinez, A., Koh, G. C. C., Dias, J. M. L. et al. Substitution mutational signatures in whole-genome\u2013sequenced cancers in the UK population. Science 376, abl9283 (2022).","journal-title":"Science"},{"key":"72952_CR19","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.1038\/s41588-025-02152-y","volume":"57","author":"GCC Koh","year":"2025","unstructured":"Koh, G. C. C., Nanda, A. S., Rinaldi, G., Boushaki, S., Degasperi, A., Badja, C. et al. A redefined InDel taxonomy provides insights into mutational signatures. Nat. Genet. 57, 1132\u20131141 (2025).","journal-title":"Nat. Genet."},{"key":"72952_CR20","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1016\/j.cell.2012.04.024","volume":"149","author":"S Nik-Zainal","year":"2012","unstructured":"Nik-Zainal, S., Alexandrov, L. B., Wedge, D. C., Van Loo, P., Greenman, C. D., Raine, K. et al. Mutational processes molding the genomes of 21 breast cancers. Cell 149, 979\u2013993 (2012).","journal-title":"Cell"},{"key":"72952_CR21","doi-asserted-by":"crossref","unstructured":"Luebeck J., Huang E., Kim F., Liefeld T., Dameracharla B., Ahuja R., et al. AmpliconSuite: an end-to-end workflow for analyzing focal amplifications in cancer genomes. bioRxiv. 2024;2024.05.06.592768.","DOI":"10.1101\/2024.05.06.592768"},{"key":"72952_CR22","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1038\/s41586-024-08377-x","volume":"638","author":"KE Houlahan","year":"2025","unstructured":"Houlahan, K. E., Mangiante, L., Sotomayor-Vivas, C., Adimoelja, A., Park, S., Khan, A. et al. Complex rearrangements fuel ER+ and HER2+ breast tumours. Nature 638, 510\u2013518 (2025).","journal-title":"Nature"},{"key":"72952_CR23","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1038\/s41586-024-08107-3","volume":"635","author":"C Bailey","year":"2024","unstructured":"Bailey, C., Pich, O., Thol, K., Watkins, T. B. K., Luebeck, J., Rowan, A. et al. Origins and impact of extrachromosomal DNA. Nature 635, 193\u2013200 (2024).","journal-title":"Nature"},{"key":"72952_CR24","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1038\/s41588-020-0678-2","volume":"52","author":"H Kim","year":"2020","unstructured":"Kim, H., Nguyen, N. P., Turner, K., Wu, S., Gujar, A. D., Luebeck, J. et al. Extrachromosomal DNA is associated with oncogene amplification and poor outcome across multiple cancers. Nat. Genet. 52, 891\u2013897 (2020).","journal-title":"Nat. Genet."},{"key":"72952_CR25","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-07530-8","volume":"12","author":"T Wu","year":"2022","unstructured":"Wu, T., Wu, C., Zhao, X., Wang, G., Ning, W., Tao, Z. et al. Extrachromosomal DNA formation enables tumor immune escape potentially through regulating antigen presentation gene expression. Sci. Rep. 12, 3590 (2022).","journal-title":"Sci. Rep."},{"key":"72952_CR26","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1038\/s41586-023-05937-5","volume":"616","author":"J Luebeck","year":"2023","unstructured":"Luebeck, J., Ng, A. W. T., Galipeau, P. C., Li, X., Sanchez, C. A., Katz-Summercorn, A. C. et al. Extrachromosomal DNA in the cancerous transformation of Barrett\u2019s oesophagus. Nature 616, 798\u2013805 (2023).","journal-title":"Nature"},{"key":"72952_CR27","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1038\/ng.3771","volume":"49","author":"D Glodzik","year":"2017","unstructured":"Glodzik, D., Morganella, S., Davies, H., Simpson, P. T., Li, Y., Zou, X. et al. A somatic-mutational process recurrently duplicates germline susceptibility loci and tissue-specific super-enhancers in breast cancers. Nat. Genet. 49, 341\u2013348 (2017).","journal-title":"Nat. Genet."},{"key":"72952_CR28","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1097\/PAS.0000000000002213","volume":"48","author":"M Lennartz","year":"2024","unstructured":"Lennartz, M., L\u00f6hr, N., H\u00f6flmayer, D., Dwertmann Rico, S., von Bargen, C., Kind, S. et al. TRPS1 is a highly sensitive marker for breast cancer. Am. J. Surg. Pathol. 48, 637\u2013651 (2024).","journal-title":"Am. J. Surg. Pathol."},{"key":"72952_CR29","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1038\/nrg3152","volume":"13","author":"N Kim","year":"2012","unstructured":"Kim, N. & Jinks-Robertson, S. Transcription as a source of genome instability. Nat. Rev. Genet. 13, 204\u2013214 (2012).","journal-title":"Nat. Rev. Genet"},{"key":"72952_CR30","doi-asserted-by":"publisher","first-page":"1318","DOI":"10.1126\/science.aaz1776","volume":"369","author":"The GTEx Consortium","year":"2020","unstructured":"GTEx Consortium, T. he The GTEx Consortium atlas of genetic regulatory effects across human tissues. Science 369, 1318\u20131330 (2020).","journal-title":"Science"},{"key":"72952_CR31","doi-asserted-by":"publisher","DOI":"10.1126\/science.1260419","volume":"347","author":"M Uhl\u00e9n","year":"2015","unstructured":"Uhl\u00e9n, M., Fagerberg, L., Hallstr\u00f6m, B. M., Lindskog, C., Oksvold, P., Mardinoglu, A. et al. Tissue-based map of the human proteome. Science 347, 1260419 (2015).","journal-title":"Science"},{"key":"72952_CR32","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1038\/nature25507","volume":"555","author":"M Macheret","year":"2018","unstructured":"Macheret, M. & Halazonetis, T. D. Intragenic origins due to short G1 phases underlie oncogene-induced DNA replication stress. Nature 555, 112\u2013116 (2018).","journal-title":"Nature"},{"key":"72952_CR33","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1038\/s41580-022-00474-x","volume":"23","author":"E Petermann","year":"2022","unstructured":"Petermann, E., Lan, L. & Zou, L. Sources, resolution and physiological relevance of R-loops and RNA\u2013DNA hybrids. Nat. Rev. Mol. Cell Biol. 23, 521\u2013540 (2022).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"72952_CR34","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-024-03278-8","volume":"25","author":"P Rojas","year":"2024","unstructured":"Rojas, P., Wang, J., Guglielmi, G., Sadurn\u00ec, M. M., Pavlou, L., Leung, G. H. D. et al. Genome-wide identification of replication fork stalling\/pausing sites and the interplay between RNA Pol II transcription and DNA replication progression. Genome Biol. 25, 126 (2024).","journal-title":"Genome Biol."},{"key":"72952_CR35","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1093\/jnci\/djt067","volume":"105","author":"LJ Solin","year":"2013","unstructured":"Solin, L. J., Gray, R., Baehner, F. L., Butler, S. M., Hughes, L. L., Yoshizawa, C. et al. A multigene expression assay to predict local recurrence risk for ductal carcinoma in situ of the breast. JNCI J. Natl. Cancer Inst. 105, 701\u2013710 (2013).","journal-title":"JNCI J. Natl. Cancer Inst."},{"key":"72952_CR36","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1016\/j.ccell.2023.04.002","volume":"41","author":"SJ Hutten","year":"2023","unstructured":"Hutten, S. J., de Bruijn, R., Lutz, C., Badoux, M., Eijkman, T., Chao, X. et al. A living biobank of patient-derived ductal carcinoma in situ mouse-intraductal xenografts identifies risk factors for invasive progression. Cancer Cell 41, 986\u20131002.e9 (2023).","journal-title":"Cancer Cell"},{"key":"72952_CR37","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1038\/nm.4292","volume":"23","author":"H Davies","year":"2017","unstructured":"Davies, H., Glodzik, D., Morganella, S., Yates, L. R., Staaf, J., Zou, X. et al. HRDetect is a predictor of BRCA1 and BRCA2 deficiency based on mutational-signatures. Nat. Med. 23, 517\u2013525 (2017).","journal-title":"Nat. Med."},{"key":"72952_CR38","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1038\/s41586-022-04403-y","volume":"602","author":"MAM Reijns","year":"2022","unstructured":"Reijns, M. A. M., Parry, D. A., Williams, T. C., Nadeu, F., Hindshaw, R. L., Rios Szwed, D. O. et al. Signatures of TOP1 transcription-associated mutagenesis in cancer and germline. Nature 602, 623\u2013631 (2022).","journal-title":"Nature"},{"key":"72952_CR39","doi-asserted-by":"publisher","first-page":"1526","DOI":"10.1038\/s41591-019-0582-4","volume":"25","author":"J Staaf","year":"2019","unstructured":"Staaf, J., Glodzik, D., Bosch, A., Vallon-Christersson, J., Reutersw\u00e4rd, C., H\u00e4kkinen, J. et al. Whole-genome sequencing of triple-negative breast cancers in a population-based clinical study. Nat. Med. 25, 1526\u20131533 (2019).","journal-title":"Nat. Med"},{"key":"72952_CR40","doi-asserted-by":"publisher","DOI":"10.1038\/s41523-021-00255-3","volume":"7","author":"N Li","year":"2021","unstructured":"Li, N., Zethoven, M., McInerny, S., Devereux, L., Huang, Y. K., Thio, N. et al. Evaluation of the association of heterozygous germline variants in NTHL1 with breast cancer predisposition: an international multi-center study of 47,180 subjects. npj Breast Cancer 7, 52 (2021).","journal-title":"npj Breast Cancer"},{"key":"72952_CR41","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1016\/S1470-2045(22)00284-4","volume":"23","author":"SJ Howell","year":"2022","unstructured":"Howell, S. J., Casbard, A., Carucci, M., Ingarfield, K., Butler, R., Morgan, S. et al. Fulvestrant plus capivasertib versus placebo after relapse or progression on an aromatase inhibitor in metastatic, oestrogen receptor-positive, HER2-negative breast cancer (FAKTION): overall survival, updated progression-free survival, and expanded biomarker analysis from a randomised, phase 2 trial. Lancet Oncol. 23, 851\u2013864 (2022).","journal-title":"Lancet Oncol."},{"key":"72952_CR42","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1038\/nrclinonc.2015.117","volume":"12","author":"R Jeselsohn","year":"2015","unstructured":"Jeselsohn, R., Buchwalter, G., De Angelis, C., Brown, M. & Schiff, R. ESR1 mutations\u2014a mechanism for acquired endocrine resistance in breast cancer. Nat. Rev. Clin. Oncol. 12, 573\u2013583 (2015).","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"72952_CR43","unstructured":"NCCN Guidelines for Patients: Ductal Carcinoma In Situ [Internet]. NCCN; 2025. Available from: https:\/\/www.nccn.org\/patients\/guidelines\/content\/PDF\/stage_0_breast-patient.pdf."},{"key":"72952_CR44","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1002\/cjp2.201","volume":"7","author":"M van Seijen","year":"2021","unstructured":"van Seijen, M., J\u00f3\u017awiak, K., Pinder, S. E., Hall, A., Krishnamurthy, S., Thomas, J. S. et al. Variability in grading of ductal carcinoma in situ among an international group of pathologists. J. Pathol. Clin. Res. 7, 233\u2013242 (2021).","journal-title":"J. Pathol. Clin. Res."},{"key":"72952_CR45","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.1200\/JCO.19.00510","volume":"38","author":"ES Hwang","year":"2020","unstructured":"Hwang, E. S., Hyslop, T., Hendrix, L. H., Duong, S., Bedrosian, I., Price, E. et al. Phase II single-arm study of preoperative letrozole for estrogen receptor\u2013positive postmenopausal ductal carcinoma in situ: CALGB 40903 (Alliance). J. Clin. Oncol. 38, 1284\u20131292 (2020).","journal-title":"J. Clin. Oncol."},{"key":"72952_CR46","doi-asserted-by":"publisher","first-page":"e026797","DOI":"10.1136\/bmjopen-2018-026797","volume":"9","author":"ES Hwang","year":"2019","unstructured":"Hwang, E. S., Hyslop, T., Lynch, T., Frank, E., Pinto, D., Basila, D. et al. The COMET (Comparison of Operative versus Monitoring and Endocrine Therapy) trial: a phase III randomised controlled clinical trial for low-risk ductal carcinoma in situ (DCIS). BMJ Open 9, e026797 (2019).","journal-title":"BMJ Open"},{"key":"72952_CR47","unstructured":"QuantumLeap Healthcare Collaborative. DCIS: RECAST Trial -Ductal Carcinoma In Situ: Re-Evaluating Conditions for Active Surveillance Suitability as Treatment: a Breast Cancer Prevention Pilot Study [Internet]. clinicaltrials.gov; 2025 Jun [cited 2025 Jul 21]. Report No.: NCT06075953. Available from: https:\/\/clinicaltrials.gov\/study\/NCT06075953."},{"key":"72952_CR48","doi-asserted-by":"publisher","first-page":"5870","DOI":"10.1245\/s10434-024-15459-7","volume":"31","author":"SA McIntosh","year":"2024","unstructured":"McIntosh, S. A., Mactier, M., Fairhurst, K., Gath, J., Stobart, H. & Potter, S. Understanding patient experiences to inform future studies to optimize personalization of treatment for early breast cancer. Ann. Surg. Oncol. 31, 5870\u20135879 (2024).","journal-title":"Ann. Surg. Oncol."},{"key":"72952_CR49","doi-asserted-by":"publisher","first-page":"e158","DOI":"10.1002\/bjs.10741","volume":"105","author":"L Ryd\u00e9n","year":"2018","unstructured":"Ryd\u00e9n, L., Loman, N., Larsson, C., Hegardt, C., Vallon-Christersson, J., Malmberg, M. et al. Minimizing inequality in access to precision medicine in breast cancer by real-time population-based molecular analysis in the SCAN-B initiative. Br. J. Surg. 105, e158\u2013e168 (2018).","journal-title":"Br. J. Surg."},{"key":"72952_CR50","doi-asserted-by":"publisher","DOI":"10.1186\/s13073-015-0131-9","volume":"7","author":"LH Saal","year":"2015","unstructured":"Saal, L. H., Vallon-Christersson, J., H\u00e4kkinen, J., Hegardt, C., Grabau, D., Winter, C. et al. The Sweden Cancerome Analysis Network - Breast (SCAN-B) Initiative: a large-scale multicenter infrastructure towards implementation of breast cancer genomic analyses in the clinical routine. Genome Med. 7, 20 (2015).","journal-title":"Genome Med"},{"key":"72952_CR51","unstructured":"cancerit\/CaVEMan [Internet]. CASM IT; 2025 [cited 2025 Sep 16]. Available from: https:\/\/github.com\/cancerit\/CaVEMan."},{"key":"72952_CR52","unstructured":"cancerit\/cgpPindel [Internet]. CASM IT; 2025 [cited 2025 Sep 16]. Available from: https:\/\/github.com\/cancerit\/cgpPindel."},{"key":"72952_CR53","unstructured":"cancerit\/BRASS [Internet]. CASM IT; 2025 [cited 2025 Sep 16]. Available from: https:\/\/github.com\/cancerit\/BRASS."},{"key":"72952_CR54","unstructured":"cancerit\/ascatNgs [Internet]. CASM IT; 2025 [cited 2025 Sep 16]. Available from: https:\/\/github.com\/cancerit\/ascatNgs."},{"key":"72952_CR55","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1038\/s41586-020-2308-7","volume":"581","author":"KJ Karczewski","year":"2020","unstructured":"Karczewski, K. J., Francioli, L. C., Tiao, G., Cummings, B. B., Alf\u00f6ldi, J., Wang, Q. et al. The mutational constraint spectrum quantified from variation in 141,456 humans. Nature 581, 434\u2013443 (2020).","journal-title":"Nature"},{"key":"72952_CR56","unstructured":"Cosmic. COSMIC - Catalogue of Somatic Mutations in Cancer [Internet]. [cited 2025 Jul 28]. Available from: https:\/\/cancer.sanger.ac.uk\/cosmic."},{"key":"72952_CR57","doi-asserted-by":"publisher","first-page":"D941","DOI":"10.1093\/nar\/gky1015","volume":"47","author":"JG Tate","year":"2019","unstructured":"Tate, J. G., Bamford, S., Jubb, H. C., Sondka, Z., Beare, D. M., Bindal, N. et al. COSMIC: the catalogue of somatic mutations in cancer. Nucleic Acids Res. 47, D941\u2013D947 (2019).","journal-title":"Nucleic Acids Res."},{"key":"72952_CR58","unstructured":"Wang (\u738b\u8bd7\u7fd4) S. ShixiangWang\/install_GISTIC [Internet]. 2025 [cited 2025 Sep 16]. Available from: https:\/\/github.com\/ShixiangWang\/install_GISTIC."},{"key":"72952_CR59","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1038\/s43018-020-0027-5","volume":"1","author":"A Degasperi","year":"2020","unstructured":"Degasperi, A., Amarante, T. D., Czarnecki, J., Shooter, S., Zou, X., Glodzik, D. et al. A practical framework and online tool for mutational signature analyses show intertissue variation and driver dependencies. Nat. Cancer 1, 249\u2013263 (2020).","journal-title":"Nat. Cancer"},{"key":"72952_CR60","unstructured":"Nik-Zainal-Group\/signature.tools.lib [Internet]. Nik-Zainal Group; 2025 [cited 2025 Sep 16]. Available from: https:\/\/github.com\/Nik-Zainal-Group\/signature.tools.lib."},{"key":"72952_CR61","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.ygeno.2017.01.005","volume":"109","author":"Y Guo","year":"2017","unstructured":"Guo, Y., Dai, Y., Yu, H., Zhao, S., Samuels, D. C. & Shyr, Y. Improvements and impacts of GRCh38 human reference on high throughput sequencing data analysis. Genomics 109, 83\u201390 (2017).","journal-title":"Genomics"},{"key":"72952_CR62","doi-asserted-by":"publisher","DOI":"10.1038\/s41523-022-00465-3","volume":"8","author":"J Staaf","year":"2022","unstructured":"Staaf, J., H\u00e4kkinen, J., Hegardt, C., Saal, L. H., Kimbung, S., Hedenfalk, I. et al. RNA sequencing-based single sample predictors of molecular subtype and risk of recurrence for clinical assessment of early-stage breast cancer. npj Breast Cancer 8, 94 (2022).","journal-title":"npj Breast Cancer"},{"key":"72952_CR63","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-08200-y","volume":"10","author":"V Deshpande","year":"2019","unstructured":"Deshpande, V., Luebeck, J., Nguyen, N. P. D., Bakhtiari, M., Turner, K. M., Schwab, R. et al. Exploring the landscape of focal amplifications in cancer using AmpliconArchitect. Nat. Commun. 10, 392 (2019).","journal-title":"Nat. Commun."},{"key":"72952_CR64","unstructured":"Bioconductor Package Maintainer. liftOver: Changing genomic coordinate systems with rtracklayer::liftOver. [Internet]. 2025. Available from: https:\/\/bioconductor.org\/packages\/liftOver."},{"key":"72952_CR65","unstructured":"gerstung-lab\/MutationTimeR [Internet]. Gerstung Lab; 2025 [cited 2026 Feb 18]. Available from: https:\/\/github.com\/gerstung-lab\/MutationTimeR."},{"key":"72952_CR66","doi-asserted-by":"publisher","first-page":"D303","DOI":"10.1093\/nar\/gkab1103","volume":"50","author":"R Lin","year":"2022","unstructured":"Lin, R., Zhong, X., Zhou, Y., Geng, H., Hu, Q., Huang, Z. et al. R-loopBase: a knowledgebase for genome-wide R-loop formation and regulation. Nucleic Acids Res. 50, D303\u2013D315 (2022).","journal-title":"Nucleic Acids Res."},{"key":"72952_CR67","doi-asserted-by":"publisher","first-page":"D966","DOI":"10.1093\/nar\/gkae1078","volume":"53","author":"JM Mudge","year":"2025","unstructured":"Mudge, J. M., Carbonell-Sala, S., Diekhans, M., Martinez, J. G., Hunt, T., Jungreis, I. et al. GENCODE 2025: reference gene annotation for human and mouse. Nucleic Acids Res. 53, D966\u2013D975 (2025).","journal-title":"Nucleic Acids Res"},{"key":"72952_CR68","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1093\/bioinformatics\/bts034","volume":"28","author":"JT Leek","year":"2012","unstructured":"Leek, J. T., Johnson, W. E., Parker, H. S., Jaffe, A. E. & Storey, J. D. The sva package for removing batch effects and other unwanted variation in high-throughput experiments. Bioinformatics 28, 882\u2013883 (2012).","journal-title":"Bioinformatics"},{"key":"72952_CR69","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1093\/bioinformatics\/btp616","volume":"26","author":"MD Robinson","year":"2010","unstructured":"Robinson, M. D., McCarthy, D. J. & Smyth, G. K. edgeR: a Bioconductor package for differential expression analysis of digital gene expression data. Bioinformatics 26, 139\u2013140 (2010).","journal-title":"Bioinformatics"},{"key":"72952_CR70","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.1200\/JCO.2008.18.1370","volume":"27","author":"JS Parker","year":"2009","unstructured":"Parker, J. S., Mullins, M., Cheang, M. C. U., Leung, S., Voduc, D., Vickery, T. et al. Supervised risk predictor of breast cancer based on intrinsic subtypes. J. Clin. Oncol. 27, 1160\u20131167 (2009).","journal-title":"J. Clin. Oncol."},{"key":"72952_CR71","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/s13058-015-0520-4","volume":"17","author":"X Zhao","year":"2015","unstructured":"Zhao, X., R\u00f8dland, E. A., Tibshirani, R. & Plevritis, S. Molecular subtyping for clinically defined breast cancer subgroups. Breast Cancer Res. BCR 17, 29 (2015).","journal-title":"Breast Cancer Res. BCR"},{"key":"72952_CR72","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","volume":"57","author":"Y Benjamini","year":"1995","unstructured":"Benjamini, Y. & Hochberg, Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J. R. Stat. Soc. Ser. B Methodol. 57, 289\u2013300 (1995).","journal-title":"J. R. Stat. Soc. Ser. B Methodol."},{"key":"72952_CR73","unstructured":"Chakravarty D., Gao J., Phillips S., Kundra R., Zhang H., Wang J., et al. OncoKB: a precision oncology knowledge base. JCO Precis. Oncol. 10, 1\u201316 (2017)."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-72952-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-72952-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-72952-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T00:14:10Z","timestamp":1784679250000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-72952-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,19]]},"references-count":73,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["72952"],"URL":"https:\/\/doi.org\/10.1038\/s41467-026-72952-1","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,19]]},"assertion":[{"value":"13 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"HRD, GR, GCCK, AD and SNZ are inventors on patent applications encompassing the code and intellectual principle of: the HRDetect algorithm (PCT\/EP2017\/060294 \u2013 granted US, JP, ER) (HRD, SNZ), clinical predictors (PCT\/EP2017\/060298 \u2013 granted US, ER) (HRD, SNZ), rearrangement signature methods (PCT\/EP2017\/060279 \u2013 granted CA, US, JP, EP) (SNZ), indel signature methods (PCT\/EP2024\/077959 \u2013 filed US, EP) (GCCK, SNZ), PRRDetect algorithm (PCT\/EP2024\/078030 \u2013 filed US, EP) (GCCK, GR, SNZ) and mutational signatures method (PCT\/EP2023\/056078 \u2013 files US, EP) (AD, SNZ). VB is a co-founder, serves on the scientific advisory board of Boundless Bio, Inc., and Abterra Inc, and holds equity in both companies. PSM is a co-founder of Boundless Bio. He has equity in the company and chairs the scientific advisory board, for which he is compensated. No potential conflicts of interest were disclosed by the other authors.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"6931"}}